Skip to main content

Table 1 Patient demographic information

From: Effects of Neurally Adjusted Ventilatory Assist (NAVA) levels in non-invasive ventilated patients: titrating NAVA levels with electric diaphragmatic activity and tidal volume matching

Patients

Gender

Age

BMI*

SAPSII*

Clinical diagnosis

1

F

62

20.27

33

Exacerbation of COPD*

2

F

69

36.73

26

Pneumonia

3

F

56

16.7

33

Exacerbation of COPD

4

M

64

22.49

54

Acute renal failure

5

F

68

23.44

33

Asthma

6

M

75

26.12

34

Sepsis

7

M

87

23.67

28

Exacerbation of COPD

8

M

72

40.04

29

Exacerbation of COPD

9

M

87

27.68

30

Exacerbation of COPD

10

F

64

29.14

29

Cardiogenic pulmonary edema

11

F

79

27.97

30

Pneumonia

12

M

78

27.70

34

Drug intoxication

Median [IQR*]

 

70.5 [64.0-78.5]

26.9 [23.0-29.0]

31.5 [29.0-33.5]

 
  1. *COPD Chronic obstruct pulmonary disease, IQR Interquartile range, BMI Body mass index, SAPSII Simplified acute physiology score.